InvestorsHub Logo
Followers 70
Posts 2099
Boards Moderated 1
Alias Born 07/04/2019

Re: None

Thursday, 07/03/2025 3:00:52 PM

Thursday, July 03, 2025 3:00:52 PM

Post# of 14
Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

https://www.globenewswire.com/news-release/2025/06/30/3107830/0/en/Jupiter-Neurosciences-Showcases-Nugevia-PWR-Mitochondrial-Optimization-Supplement-Designed-to-Boost-Energy-Endurance-and-Recovery.html

=================

Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science

https://finance.yahoo.com/news/jupiter-neurosciences-unveils-nugevia-glo-120000709.html?guccounter=1&guce_referrer=aHR0cHM6Ly9kdWNrZHVja2dvLmNvbS8&guce_referrer_sig=AQAAAJeEVM9KLf4BVOujCNJY4jlBJmM4tD5WPFb25DnQFZS3bgnJFwcGVfcTXi8nFBeqKrWBz93daRnaSg5yVjbnJSI5sfo29CC5TfufUj-cy9WTcbqheU4ieJ-fVgN7D-dSo_WNfeiecUj2rYD_2rKf59CwTTeNZKMvphI55fTXEziZ

=================

Jupiter Neurosciences to launch mitochondrial health supplement this fall

https://www.investing.com/news/company-news/jupiter-neurosciences-to-launch-mitochondrial-health-supplement-this-fall-93CH-4117651

=================

About Jupiter Neurosciences, Inc.
Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia™ product line. Both efforts are powered by JOTROL™, Jupiter’s proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability. Nugevia brings clinical-grade science to the supplement space, supporting mental clarity, skin health, and mitochondrial function. The Company’s prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson’s disease, includeing indications such as Alzheimer’s Disease, Mucopolysaccharidoses Type I, Friedreich’s Ataxia, and MELAS. More information may be found on the Company’s website www.jupiterneurosciences.com.

$JUNS 💹

Don't invest what you can't afford to lose. Always do your own DD. INV4$

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JUNS News